
Cape Cod 2025 Pharmacology & Primary Care Conference (Recorded)
-
Register
- User - $319.50
Cape Cod bundle description: In this 2025 previously recorded conference bundle learn about pharmacology and primary care topics ranging from women's health, anticoagulants, PCOS, tobacco use in adolescents, to our sexual health workshop. This bundle is an excellent way to catch up with unique topics with 17 total credits and 9.75 total pharmacology credits.
*Due to rapidly changing clinical knowledge, once purchased, you have 90 days access to complete this education. The expiration date below is for the product and doesn't not affect your 90 days access.
Total Credits: 17 Contact Hours; 9.75 are Pharmacology
This activity has been reviewed by the American Academy of Physician Associates Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 18 AAPA Category 1 CME credits. Approval is valid from 6/9/2025 to 6/8/2026. PAs should only claim credit commensurate with the extent of their participation.
Expiration Date: May 31st, 2026
$ 355
$319.50
-
Includes Credits
Uncomplicated and complicated UTI’s are commonly encountered in primary care and emergency settings. Using a case study approach, this session will focus on the management of a UTI’s in the following: the older individual, the person with an indwelling catheter or a structural abnormality, and those with pyelonephritis. In addition, a discussion regarding antimicrobial resistance and its impact on treating the complicated and uncomplicated UTI will be offered. | 1.5 CE/CME category 1 credits (1.50 Pharmacology) | $40
-
Includes Credits
Since electronic nicotine delivery systems or ENDs (e-cigarettes), came to the US market in 2006, their use has increased exponentially, especially in the adolescents along with a proliferation and evolution of devices. Use of ENDs in adolescents has exposed them to nicotine containing tobacco products and well as other substances. There has been some evidence that e-Cigarettes may have some efficacy as a harm reduction tool in certain long term combustible tobacco users, the identification of serious known and potential harms are increasing. We will discuss the evolution of these products, current trends in use, known and potential harms, their potential as harm reduction tool, and their overall impact on public health, and changes in health policies. | 1.0 CE/CME category 1 credits (1.00 Pharmacology) | $30
-
Includes Credits
This session discusses the diagnosis and treatment of alcohol associated liver disease. Included in this session the complications of liver disease and treatment options are discussed in detail for the outpatient and inpatient setting. | 1.0 CE/CME category 1 credits (0.50 Pharmacology) | $30
-
Includes Credits
Understand negative effects of stress, define extreme self-care, and describe the benefits of being a healthy role model. Discuss strategies for lifelong prevention/management of stress. Learn how to break unhealthy habits and how to create healthy habits and how to sustain these new healthy habits over time. | 1.0 CE/CME category 1 credits (0.0 Pharmacology) | $10
-
Includes Credits
Discuss the epidemiology, complex pathophysiology, associated risks and complications. List symptoms, signs & explain diagnostic work-up including the complex differential process. Describe evidence-based management approaches including pharmacologic and non-pharmacologic treatments and lifestyle modifications. | 1.5 CE/CME category 1 credits (1.00 Pharmacology) | $35
-
Includes Credits
This session will focus on pharmacologic strategies to retard progression of chronic kidney disease (RAS blockade, GLP-1 analogues, SGLT-2 inhibitors, and non-steroidal mineralocorticoid antagonists) as well as treatment of chronic kidney disease complications such as hyperkalemia, chronic kidney disease associated pruritus, and anemia. Since cardiovascular disease is the leading cause of death in patients with chronic kidney disease, this session will also focus on the interplay between chronic kidney disease and cardiovascular disease and pharmacologic and non-pharmacologic interventions to reduce the risk of adverse cardiovascular events in this patient population. | 1.5 CE/CME category 1 credits (1.00 Pharmacology) | $35
-
Includes Credits
This session discusses many types of pain that can be musculoskeletal but could also be something more serious, when NOT to miss a life threatening diagnosis. | 1.5 CE/CME category 1 credits (0.25 Pharmacology) | $35
-
Includes Credits
This presentation will cover normal female sexual development, common myths and misperceptions about female sexual health, common female sexual health concerns and female sexual problem management. | 3.0 CE/CME category 1 credits (2.00 Pharmacology) | $70
-
Includes Credits
This session discusses the diagnosis and treatment of hypogonadism and testosterone replacement. What we can and cannot give and what the latest data tells us. | 1.0 CE/CME category 1 credits (1.00 Pharmacology) | $30
-
Includes Credits
This fun and enlightening presentation for primary care providers will evaluate safe and effective prescribing by considering more than just medication costs. Cost-effective prescribing also means avoiding drug-drug and drug-disease interactions so that patients get the most out of the medications they take. | 1.5 CE/CME category 1 credits (1.50 Pharmacology) | $40